- $51.41bn
- $49.84bn
- $66.91bn
- 61
- 73
- 79
- 82
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 69,750 | 67,842 | 68,696 | 68,770 | 66,905 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 62,000 | 60,002 | 59,258 | 61,468 | 63,698 |
Operating Profit | 7,750 | 7,840 | 9,438 | 7,302 | 3,207 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 6,795 | 6,927 | 8,518 | 6,364 | 2,162 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,909 | 5,418 | 6,876 | 5,302 | 1,602 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5,899 | 5,407 | 6,855 | 5,284 | 1,578 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5,721 | 5,191 | 6,654 | 5,099 | 1,380 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.18 | 5.68 | 7.7 | 6.31 | 1.81 |
Dividends per Share |